microRNAs (miRNAs) are an abundant class of small noncoding RNAs that function primarily as oncogenes and tumor suppressors by mediating translational repression or mRNA degradation via binding target genes. In this study, malignant human bronchial epithelial cells transformed by anti-benzo[a]pyrenetrans-7,8-diol-9,10-epoxide were used to help characterize the possible mechanisms of miRNA function in chemical carcinogenesis. The expression level of miR-106a was measured by the realtime, reverse transcriptase polymerase chain reaction. We used the miR-106a inhibitor and the miR-106a mimic to downregulate or upregulate miR-106a activity in malignantly transformed cells to determine the effects of miR-106a on the biological properties of the cell. We observed overrepresentation of miR-106a in transformed cells compared with control cells. Silencing miR-106a by transfection with the miR-106a inhibitor suppressed cell proliferation, induced cell cycle arrest and apoptosis, and inhibited anchorage-independent growth and tumor growth in nude mice. Increasing miR-106a in malignantly transformed cells by transfection with the miR-106a mimic gave the opposite results. Moreover, untransformed cells showed a reduction of cell cycle arrest and apoptosis rate followed by transfection with the miR-106a mimic. Bioinformatic analysis showed that tumor suppressor RB1 is one of predictive targets of miR-106a. We confirmed this target by Western blot and dual luciferase assay. Our findings suggest that miR-106a might function as an oncogene in transformation induced by a chemical carcinogen. Thus, knock down of miR-106a in malignant cells is a potential therapeutic strategy.
Lung cancer is one of the most common forms of cancer in humans and is the leading cause of cancer-related death worldwide. Most cases of lung cancer are induced by environmental carcinogens, particularly tobacco smoke (Parkin, 2001) . The polycyclic aromatic hydrocarbon benzo [a] pyrene (B[a]P), which is a toxic element in the environment in general and in tobacco smoke in particular, has atherogenic and carcinogenic properties (Duarte and Paschoal, 2006; Pfeifer et al., 2002) . B[a]P is activated by microsomal enzymes to yield anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE), which binds covalently to nuclear DNA forming BPDE-DNA adducts that can initiate carcinogenesis (Kelley et al., 2005; Xie et al., 2003) . Cellular studies and animal studies have concluded that there is evidence that an increased risk of tumorigenesis is associated with BPDE adduct formation (de Vries et al., 1997; Sharma et al., 2008; Vayssier-Taussat et al., 2001; Wu et al., 2009) . However, the mechanism involved in anti-BPDEinduced tumorigenesis is not fully understood.
Like other cancers, the development of lung cancer is a multistep process including the accumulation of genetic and epigenetic changes (Damps et al., 2001; Minna et al., 2002) . microRNAs (miRNAs) are a class of naturally occurring, small noncoding RNAs that control gene expression by targeting mRNAs for translational repression or cleavage (Du and Zamore, 2005; Pillai, 2005) . As a new layer of gene regulation, miRNAs have diverse functions, including the regulation of cellular differentiation, proliferation, and apoptosis (Croce and Calin, 2005) . Aberrant miRNA expression has been reported frequently in various tumors, including breast cancer (Shimono et al., 2009) , leukemia (Zanette et al., 2007) , lung cancer (Cho, 2009; Keller et al., 2009) , and colon cancer (Akao et al., 2007) , indicating that there is a correlation between miRNAs and human malignancy. A malignant transformation model of the human bronchial epithelial cell line 16HBE induced by anti-BPDE has been established in our laboratory. The immortalized 16HBE cell line retains the specific morphology and function of normal human bronchial epithelial cells and provides a suitable resource for studying the molecular pathogenesis of lung cancer. In earlier studies in our laboratory, 55 significantly differentially expressed miRNAs were identified by microarray in transformed 16HBE cells (Shen et al., 2009) . We speculated that some of these miRNAs might have important roles in the process of anti-BPDE-induced transformation of 16HBE cells. Among these miRNAs, miR-106a and miR-18b belong to the miR-106a~363 cluster (Hayashita et al., 2005; Ventura et al., 2008) . On the basis of bioinformatic analysis, we selected the highly expressed miRNAs miR-106a, miR-17-5p, miR-20a, and miR-18b for further study. Gene Ontology (GO) analysis (http://www.geneontology. org/) revealed that these miRNAs might target genes involved in the regulation of biological processes, including apoptosis and the cell cycle pathways. These miRNAs share the same seed sequence but miR-106a was the most highly expressed and miR-17-5p, miR-20a, and miR-18b displayed less effect than miR-106a in our preliminary experiments. miR-106a has been reported to be a potential oncogenic, noncoding RNA in T-cell lymphoma (Lum et al., 2007) . These results prompted us to focus on the functions of miR106a in anti-BPDE-induced transformation of 16HBE cells.
To gain a better understanding of the effects of miR-106a on the biological properties of transformed or untransformed 16HBE cells, we used the miR-106a inhibitor for a loss-offunction study and the miR-106a mimic for a gain-of-function study. We introduced computational methodology (TargetScan and DIANA) for miR-106a target predictions and GO analysis of the predicted targets. We found that tumor suppressor RB1 is one of predictive targets. Western blot analysis and dual-luciferase assays indicated that RB1 is a direct target for miR-106a. This is the first report of the role of miR-106a in carcinogenesis. The results of this study increase our knowledge of the significance of miRNA in the process of anti-BPDE-induced transformation of human bronchial epithelial cells and provide a novel therapeutic strategy against chemical carcinogenesis.
MATERIALS AND METHODS
Cell culture. A malignant transformed cell line (16HBE-T) derived from the human bronchial epithelial cell line 16HBE (kindly provided by Professor Jun Xu, Guangzhou Medical University) induced by anti-BPDE and a control untransformed cell line (16HBE-N) were prepared as described (Jiang et al., 2001) . Briefly, the human bronchial epithelial cell line 16HBE was treated with anti-BPDE (98.3% purity, NCI Chemical Carcinogen Reference Standard Repository, Midwest Research Institute) at a concentration of 2.0lM for 96 h, followed by 30 passages in culture. The control 16HBE cells (16HBE-N) were treated with dimethyl sulfoxide (Sigma) at a concentration equivalent to that used to create the 16HBE-T cells. Analysis of malignant features in these two cell lines by culture on soft agar and tumorigenesis in nude mice revealed that the 16HBE-T cells but not the 16HBE-N cells manifested these features (Jiang et al., 2001) . Both cell lines were grown in minimum essential medium (Gibco BRL) with 10% (vol/vol) calf serum and 1% (wt/vol) antibiotic (penicillin/ streptomycin). The cells were maintained at 37°C in a 5% (vol/vol) CO 2 atmosphere in a humidified incubator. Cells were passaged by treatment every 3 days with 0.02% (wt/vol) EDTA and 0.25% (wt/vol) trypsin (Gibco BRL) in DHanks buffer.
Quantitative real-time PCR analysis. Total cellular RNA was extracted with TRIzol reagent (Invitrogen) according to the manufacturer's recommendations. RNA quality and concentration were determined by measuring the absorbance at 260 nm (A 260 ) and at 280 nm (A 280 ) in a spectrophotometer (Nanodrop Technologies). The integrity of the large RNA was confirmed by electrophoresis in 1% (wt/vol) agarose gel under denaturing conditions. For the detection of mature miR-106a, 60 ng of total RNA, gene-specific primers (Applied Biosystems) and Moloney murine leukemia virus reverse transcriptase (Promega Corporation) were used in a real-time reaction following the manufacturer's protocol. Quantitative real-time PCR (qRT-PCR) for mature miR-106a was done with the TaqMan stem-loop kit and the TaqMan Universal PCR Master Mix from Applied Biosystems using the Applied Biosystems AB 7500 real-time PCR system as described (Chen et al., 2005) . For the detection of RB1, the extracted total RNA was reverse transcribed into cDNA using the ExScriptTM RT reagent Kit (TAKARA). The real-time PCR was done using the Real-Time PCR Universal Reagent (GenePharma) and an MX-4000 RealTime PCR Instrument (Stratagene) with SYBR Green as the detection fluorophore. The sense and antisense primers used in this study were RB1 (185 bp): 5#-GGACCGAGAAGGACCAACTG-3# 5#-GGGTCTGGAAGGCTGAGGTT-3# GAPDH (113 bp): 5#-CATGAGAAGTATGACAACAGCCT-3# 5#-AGTCCTTCCACGATACCAAAGT-3#
The relative amount of miRNA and RB1 was normalized against U6snRNA or glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and the fold change was calculated by the 2
ÀDDCt method (Livak and Schmittgen, 2001 ). Real-time PCR was done in triplicate for each sample.
RNA oligoribonucleotides and cell transfections. The antisense oligonucleotides used in these studies were the miR-106a inhibitor (anti-miR-106a):
5#-CUACCUGCACUGUAAGCACUUUU-3# and the miRNA inhibitor negative control (NC inhibitor): 5#-CAGUACUUUUGUGUAGUACAA-3# The mimics used in these studies were the miR-106a mimic: 5#-AAAAGUGCUUACAGUGCAGGUAG-3# 5#-ACCUGCACUGUAAGCACUUUUUU-3# and the miRNA mimic negative control (NC mimic): 5#-UUCUCCGAACGUGUCACGUTT-3# 5#-ACGUGACACGUUCGGAGAATT-3#
All pyrimidine nucleotides in the oligoribonucleotides were substituted by 2#-O-methyl (2#-Ome) to improve RNA stability and both control oligoribonucleotides were heterologous to any human genome sequences. The RNA oligoribonucleotides were purchased from Genepharma. The 16HBE-T cells were trypsinized, counted, and seeded in plates the day before transfection to ensure a suitable cell confluence on the day of transfection. Cells were transiently transfected using the Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's protocol. Each well contained miRNA mimic (50nM final concentration) and miRNA inhibitor (100nM final concentration). The transfection efficiency, examined by fluorescein amidite-conjugated small interfering RNA and fluorescence microscopy (Nikon Corporation), was up to 85% in the cells (data not shown). At 24 h after transfection, cells were processed for soft agarose assay and tumorigenicity studies. Cells were processed for qRT-PCR, cell cycle assay, and apoptosis assay 72 h posttransfection and for proliferation assay at 5 days posttransfection.
Western blot analysis. The cells were lysed in cell lysis buffer (Cell Signaling Technology) and harvested by scraping with a cell lifter. The protein concentrations of the lysates were measured using the BCA method (Pierce) and equivalent amounts of protein per sample were subjected to electrophoresis in SDS/10% polyacrylamide gel (SDS-PAGE). The proteins were transferred by electroelution onto polyvinylidene fluoride membranes (Millipore), which were blocked with 5% (wt/vol) nonfat dry milk in Tris-buffered saline, pH 7.4, containing 0.05% (wt/vol) Tween-20. Proteins were detected by incubation with rabbit anti-human monoclonal primary antibodies against RB1 (BioWorld) and GAPDH (BioWorld) overnight at 4°C, followed by washing extensively with 0.1% (vol/vol) Tween-20 in PBS and incubated with horseradish peroxidase-conjugated rabbit anti-mouse secondary antibody (DAKO) for 2 h at room temperature. The membrane was washed three times, and the proteins were visualized using enhanced chemiluminescence (Cell Signaling Technology) and scanned with the Gel Doc 1000 gel analysis system (Tanon) using anti-GAPDH antibody as the internal standard.
Cell cycle detection. Cells were seeded into six-well plates and allowed to attach for 24 h before transfection of oligoribonucleotides. At 72 h after transfection, the supernatant from each well was combined with cells harvested from the corresponding well by trypsinization. The cells were collected by lowspeed centrifugation, washed twice with PBS, fixed in 4 ml of cold 70% (vol/ vol) ethanol at 4°C overnight, and washed twice with 0.1% (vol/vol) Triton X-100 in PBS. The cells were stained with 20 lg/ml propidium iodide (PI) in PBS and 200 lg/ml RNase A in PBS at 37°C for 30 min, then analyzed immediately by flow cytometry (FACScan; BD Biosciences) (Song et al., 2006) . Data were gated using the FlowJo software (Tree Star).
Cell proliferation assay. For the cell proliferation assay, equal numbers of 16HBE-T cells were seeded in 96-well plates and cultured for 24 h, followed by infection with RNA oligoribonucleotides. Cell culture was continued for 5 days and assessed using the Cell Counting Kit 8 (CCK-8; Dojindo). The absorbance at 450 nm (A 450 ) of each well was determined with a microplate reader (Molecular Devices). Each test was done five times.
Apoptosis assay. Apoptosis was evaluated with the Annexin V/PI apoptosis kit (KeyGen Biotech). At 72 h posttransfection, the transfected cells and the untransfected control cells were trypsinized and washed twice with PBS. About 5 3 10 5 cells were suspended in binding buffer containing Annexin V-fluorescein isothiocyanate and PI according to the supplier's instructions and assessed by flow cytometry (FACScan; BD Biosciences).
Soft agarose assay. Soft agarose assays were used to compare the clonogenic potential of control and oligoribonucleotide-transfected cells. At 24 h posttransfection, the cells were removed by trypsinization and 500 cells from each pool were suspended in 1 ml of 0.3% (wt/vol) low-melting point agarose (Sigma) containing 10% (vol/vol) fetal bovine serum in Dulbecco's modified Eagle medium. The cells were plated on top of 1 ml of semi-solid 0.6% (wt/vol) low-melting point agarose in the same medium in 12-well plates. Three wells were plated for each group of parental cells. Colonies with at least 50 cells were counted at 3 weeks posttransfection (Shevde et al., 2006; Wang et al., 2006) . Tumorigenicity study. BALB/c nude mice (5 weeks old) were purchased from the Medical Animal Experimental Center of Guangdong Province. All animal studies conformed to institutional guidelines. At 24 h posttransfection with oligoribonucleotides, transfected, and untransfected 16HBE-T cells were harvested by trypsinization, washed twice, and suspended in PBS. Four mice per group were each given 2 3 10 6 cells in 0.2 ml of PBS and were injected subcutaneously behind each posterior limb. Growth curves for xenografts were determined by measuring tumors externally in two dimensions with a slide caliper. Tumor volume (mm 3 ) was determined from the equation (Anumanthan et al., 2005; Hao et al., 2007) :
where L is the length and W is the width of the tumor. The tumor diameter was measured every 5 days and growth curves were plotted as the mean volume ± SD of tumors from the four mice in each group. After 42 days, the mice were killed and the xenografts were excised, weighed, and fixed in buffered 4% (vol/vol) formalin for pathological examination.
Dual-luciferase assay. 16HBE-T cells were cotransfected with reporter plasmids bearing a wild-type or mutant putative miR-106a recognition element and miR-106a mimic or negative control mimic. The 3#-untranslated region (UTR) from the human RB1 gene was cloned into vector psiCHECK2, which contains the luciferase open-reading frame. Seed regions were mutated to remove complementarity to miR-106a. The 16HBE-T cells were plated in a 24-well plate and then cotransfected with plasmid with or without an miR-106a mimic for 48 h. Each sample was also cotransfected with plasmid expressing Renilla luciferase to monitor the transfection efficiency (Promega Corporation). Cells were lysed 48 h posttransfection, and the ratio between the firefly luciferase activity and the Renilla luciferase activity was measured with a dual-luciferase assay (Promega Corporation).
Statistical analysis. Values were expressed as mean ± SD from three separate experiments, unless indicated otherwise, and analyzed using SPSS 17.0 for Windows (SPSS, Inc.). Comparison of miR-106a expression between 16HBE-T cells and 16HBE-N cells was done with Student's t-test. Comparison of the proportion of cells at each phase, colony formation rate, apoptosis rate, cell proliferation, tumor volume, and tumor weight were assessed with one-way ANOVA. The level of statistical significance was set at p < 0.05 for all tests.
RESULTS

Overexpression of miR-106a and Its Change after
Transfection Figure 1A shows that the level of miR-106a was 2.9 (± 0.2)-fold higher in 16HBE-T cells than that in 16HBE-N cells as detected with TaqMan qRT-PCR (p < 0.05). Moreover, TaqMan qRT-PCR revealed that the level of miR-106a in transformed 16HBE-T cells was reduced to 0.3 (± 0.1)-fold or increased to 1.9 (± 0.3)-fold following transfection with antimiR-106a or the miR-106a mimic, respectively (Fig. 1B) , suggesting that oligoribonucleotides are introduced efficiently into 16HBE-T cells to knock down or enhance miR-106a expression. The level of miR-106a in untransformed 16HBE-N cells was increased following transfection with the miR-106a mimic (Fig. 1B) . However, the level of miR-106a in 16HBE-N cells was little changed after transfection with anti-miR-106a (data not shown). Because the original expression of miR-106a in untransformed 16HBE-N cells was low, miR-106a might function as an oncogene as described, so we focused on the role of miR-106a in 16HBE cells malignantly transformed by anti-BPDE.
Change of Cell Cycle
We used flow cytometry to examine the DNA profiles of asynchronous populations of cells that were transfected with Lipofectamine 2000 (Lipo-2000) NC, NC inhibitor, NC mimic, anti-miR-106a, miR-106a mimic, and without any transfection to monitor the effect of miR-106a on the cell cycle ( Fig. 2A) . Anti-miR-106a-transfected 16HBE-T cells differed significantly in their cell cycle distribution when compared with the NC inhibitor-transfected 16HBE-T cells with a higher pro- (Fig. 2B) .
Alteration of Cell Apoptosis and Cell Proliferation
We determined the level of apoptosis in the transfected cells (Fig. 3A) . The results showed that a significantly higher apoptotic rate was found at 72 h posttransfection in the 52 JIANG ET AL.
by guest on January 15, 2011 toxsci.oxfordjournals.org anti-miR-106a-transfected 16HBE-T cells (9.91 [± 1.39]%) compared with that of the 16HBE-T NC inhibitor group (5.43 [± 0.59]%), whereas negative control-transfected groups revealed a frequency of apoptosis similar to that of nontransfected 16HBE-T cells (Fig. 3B) . The apoptotic rate of the miR-106a mimic-transfected 16HBE-T cells and the 16HBE-N cells (2.03 [± 0.12]% and 4.58% [± 1.51]%) was significantly lower than those in the NC mimic group (4.97 [± 0.95]% and 7.62% [± 0.89]%) (Fig. 3B) . The inhibition of cell growth coincided with the induction of apoptosis for anti-miR-106a and the increase of cell growth coincided with the decrease of apoptosis for the miR-106a mimic. To test whether miR-106a can function as an oncogene in malignantly transformed 16HBE cells, we examined the effect of decreasing or increasing miR-106a on cell proliferation in 16HBE-T. The CCK-8 assay showed a significant decrease (0.37 [± 0.01]-fold) and a significant increase (0.45 [± 0.07]-fold) of cell growth at 5 days in the anti-miR-106a-transfected cells and in the miR-106a mimic-transfected cells, respectively, when compared with the control groups (p < 0.05) (Fig. 4) . All subsequent experiments were done with 16HBE-T cells.
Alteration of Clonal Growth
As the next step, the capacity for colony formation was evaluated for 16HBE-T cells with or without transfection (Fig. 5A ). Cells transfected with anti-miR-106a displayed fewer colonies (Fig. 5B) . These results support the suggestion that miR-106a affects cell proliferation, cell apoptosis, and colony formation in 16HBE-T cells.
Anti-miR-106a Suppresses and the miR-106a Mimic Promotes Tumorigenicity In Vivo
The formation of xenografts in immunocompromised mice is generally considered to be an indispensable tool for assessing the tumorigenicity of human cells. To further investigate the effect of miR-106a, we asked whether oligoribonucleotide transfection would affect tumor growth in vivo. 16HBE-T cells were injected sc on the left-hand side of BALB/c nude mice and Lipo-2000 NC-transfected cells were injected sc on the right-hand side in the first group. Other groups were injected with anti-miR-106a or miR-106a mimic-transfected cells on the left-hand side and NC inhibitor or NC mimic-transfected cells on the right-hand side. Tumors had grown at all injection sites within 7 days postinoculation. The tumors derived from anti-miR-106a-transfected cells grew substantially more slowly compared with the NC inhibitor-transfected group throughout the period of tumor growth. In sharp contrast, tumors grew fastest and largest in the sites injected with miR106a mimic transfectants (Fig. 6A) and sinusoids, with richer interstitial tissues and more necrosis, whereas the opposite results were found for the miR-106a mimic group (Fig. 6D ).
Regulation of RB1 by miR-106a
Bioinformatic analysis showed that tumor suppressor RB1 is one of predictive targets of miR-106a (Fig. 7A ). To determine whether the endogenous levels of miR-106a had a role in regulating RB1 levels, we matched the seed sequence of miR106a with that of the RB1 3#-UTR (Fig. 7B) . We measured the levels of miR-106a and RB1 before and after transfection. To compare with 16HBE-N, the level of mature miR-106a in 16HBE-T was increased, whereas RB1 decreased, showing that RB1 might be a target of miR-106a. The levels of RB1 mRNA and protein in the anti-miR-106a group were both above the levels seen in the NC inhibitor groups. In contrast, the levels of RB1 mRNA and protein in the miR-106a mimic group were both below the levels seen in the NC mimic group (Figs. 7C  and D) . In the dual-luciferase assay, the relative luciferase activity of the reporter that contained the RB1 3#-UTR was markedly decreased compared with that seen with the parent plasmid containing the mutant sequence or the NC mimic group and the 16HBE-T blank group (Fig. 7E) . The results showed that the effects of miR-106a were mediated by sequences in the 3#-UTR of RB1 mRNA, which is in agreement with the results of earlier studies.
DISCUSSION
There have been frequent reports of research on miRNAs in oncology in recent years, but the precise role of miRNAs in chemical carcinogenesis is not fully understood. The successful establishment of the malignant transformation model of 16HBE cells induced by anti-BPDE has helped studies of the miRNA mechanism involved in chemical carcinogenesis. Here, we show that the level of miR-106a was greater in transformed cells than that in untransformed control 16HBE cells. Qian et al. (2008) reported ectopic expression of several microRNAs, including miR-106a, in bronchoalveolar stem cells, which suggests the intriguing possibility that aberrant expression of microRNAs could be involved in transforming bronchoalveolar stem cells into lung cancer stem cells. Thus, the overexpression of miR-106a might have a role in the carcinogenesis of anti-BPDE. We have examined the effects of miR-106a on the biological properties of 16HBE-T cells.
Because an individual miRNA is capable of modulating the expression of a network of mRNAs and the natural function of miRNAs is specifying cellular phenotype, miRNA-based cancer gene therapy offers the theoretical appeal of targeting multiple gene networks that are controlled by a single, aberrantly expressed miRNA. Reconstitution of tumorsuppressive miRNA or a sequence-specific knock down of oncogenic miRNAs by ''antagomirs'' has produced favorable antitumor outcome in experimental models (Krutzfeldt et al., 2005 (Krutzfeldt et al., , 2006 . Esau (2008) demonstrated that inhibition by antisense oligonucleotides is considered the best and possibly the only practical approach for specific pharmacological inhibition of miRNA function. In this study, we used 2#-OMe-modified oligoribonucleotides (GenePharma) to inhibit or reinforce miR-106a activity in vitro, which allowed exploration of miR-106a function in anti-BPDE-induced transformed cells and made it feasible to assess phenotypic change in transformed cells. The functional role for miR-106a was demonstrated by loss-of-function and gain-of-function experiments and the results showed that miR-106a repression induced G 0 /G 1 cell arrest and decreased the number of cells in S phase, but its overrepresentation increased the number of cells in S phase, suggesting that miR-106a overrepresentation provides a proliferative advantage to malignant transformation cells. In our earlier study, we determined the expression levels of miR-320 and miR-494 in primary murine bronchial epithelial cells exposed to B[a]P and found they might impact B[a]P-exposed G 1 /S transition through CDK6 (Duan et al., 2010) . That study revealed that the lack of activation of miR106a with inhibitor inhibited cell proliferation and induced apoptosis in malignant transformed cells. In contrast, the overrepresentation of miR-106a with a mimic promoted proliferation and reduced apoptosis in malignant transformed cells. It is noteworthy that overrepresentation of miR-106a with a mimic in untransformed cells can reduce apoptosis. The decreased level of miR-106a suppressed the growth and tumorigenesis of malignant transformation cells, and its overrepresentation led to the opposite effects. Other researchers have reported that restoring the expression of miR-101 by introducing mimics dramatically suppressed the ability of hepatoma cells to form colonies in vitro and the development of tumors in nude mice (Su et al., 2009) .
We predicted the targets of miR-106a by TargetScan and DIANA and then GO analysis (Biological Process) of predicted targets. It is interesting to note that the predicted targets could be related to cellular processes, including cell cycle, cell death, etc. The predictive targets of miR-106a included RB1, p21, and RBPl like, which could be related to tumor development. In our subsequent experiments, we found that RB1 played an increasingly prominent role. The change of miR-106a could decrease the expression of RB1 mRNA and protein, indicating that there is a close correlation between miR-106a and RB1. We validated this prediction by dual-luciferase assay. One of the mechanisms of miR-106a in tumorigenesis is likely to be involved in targeting tumor suppressor RB1, which can promote cell apoptosis (Volinia et al., 2006) . The retinoblastoma tumor suppressor gene product RB1 regulates differentiation, apoptosis, and cell cycle control by coordinating the cell cycle at G 1 /S with transcriptional machinery. Ectopic expression of miRNAs might promote tumor formation by downregulating large numbers of target tumor suppressors and by modulating functions of proto-oncogenes to enhance their oncogenic activities while keeping their antioncogenic effects, such as apoptosis induction, to a minimum (Sini et al., 2009) . Further studies are needed to validate target genes other than RB1 for miR-106a, which will be important for a full understanding of how expression of this miRNA confers selective advantages on 16HBE-T proliferation, anchorage-independent growth, and tumorigenesis, and to determine whether miR-106a knockdown-induced cell cycle arrest and apoptosis are general phenomena in chemically induced oncogenesis.
In summary, our results show that inhibition or reinforcement of endogenous miR-106a by the inhibitor or mimic in malignantly transformed cells induced by anti-BPDE induces entirely different cell-growth properties. Therefore, miR-106a might function as an oncogene and might serve as a potential target for cancer therapy. This study offers further insight into the functions of miRNAs in the processes of chemical carcinogenesis. 
